2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-, (6S)- (106092-09-5)

Identification
Name:	2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-, (6S)-
Synonyms:	2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-, (S)-;(S)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;(S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine;s-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole;
CAS:	106092-09-5
Molecular Formula:	C₇H₁₁N₃S
Molecular Weight:	169.24
InChI:	InChI=1/C7H11N3S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h4H,1-3,8H2,(H2,9,10)/t4-/m0/s1
Molecular Structure:
Properties
Flash Point:	170.9oC
Boiling Point:	359 oC at 760 mmHg
Density:	1.313 g/cm³
Refractive index:	1.656
Appearance:	off-white powder
Flash Point:	170.9oC
Usage:	(S)-Pramipexole intermediate as dopamine autoreceptor agonist.
Safety Data

Other Product

2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-, hydrochloride (1:2), (6S)-
2,5-Benzothiazolediamine,6-chloro-
2,5-Benzothiazolediamine,6-methyl-
2,7-Benzothiazolediamine,6-nitro-
2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-N6-propyl-, (6S)-
4,7-Benzothiazolediamine,6-methoxy-(9CI)
2,5-Benzothiazolediamine,6-nitro-(9CI)
2H-Pyran-2-acetamide,N-[(2E,4E,6S,7R)-7- [(2S,3S,4R,5R)-5-[(1E,3E,5E)-7-(1,2- dihydro-4-hydroxy-2-oxo-3-pyridinyl)-6- methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,- 4-dihydroxy-2-furanyl]-6-methoxy-5- methyl-2,4-octadienyl]tetrahydro-2,4- dihydroxy-R,5-dimethyl-6-(1,3-pentadienyl)-,(RS,2S,5S,6S)-
(4R,6S,7R,7aS)-7-(((2R,3R,6S)-6-(acetamidomethyl)-3-(((benzyloxy)carbonyl)amino)tetrahydro-2H-pyran-2-yl)oxy)-6-(((benzyloxy)carbonyl)amino)-2,2-dimethyl-4-nitrohexahydrobenzo[d][1,3]dioxol-5-yl acetate
2,6-Benzothiazolediamine,4,5,6,7-tetrahydro-, hydrochloride (1:2)
2-Naphthalenol,5,6,7,8-tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-, (5R,6S)-
2-Naphthalenol,5,6,7,8-tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-,(5R,6S)-rel-
5,12-Naphthacenedione,8-ethyl-7,8,9,10-tetrahydro- 1,6,8,11-tetrahydroxy-10-[[2,3,6- trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)- tetrahydro-6-methyl-5-oxo-2H-pyran-2- yl]-R-L-lyxo-hexopyranosyl]-3-(dimethylamino)- R-L-lyxo-hexopyranosyl]oxy]-7-[[2,3,- 6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,- 6S)-tetrahydro-6-methyl-5-[[(2S,5S,6S)- tetrahydro-5-hydroxy-6-methyl-2H-pyran- 2-yl]oxy]-2H-pyran-2-yl]-R-L-lyxohexopyranosyl] oxy]-,(7R,8R,10S)-
2H-Pyran-2-one,tetrahydro-4-hydroxy-5-methyl-6-(1-methylethyl)-,(4S,5R,6S)-(9CI)
2H-Pyran-2-acetamide,N-[7-[5-[7-(1,2- dihydro-4-hydroxy-2-oxo-3-pyridinyl)-6- methyl-7-oxo-1,3,5-heptatrienyl]tetrahydro-3,- 4-dihydroxy-2-furanyl]-6-methoxy-5- methyl-2,4-octadienyl]-R-ethyltetrahydro-2,- 4-dihydroxy-5-methyl-6-(1,3-pentadienyl)-,[2S,2[S[2E,4E,6S,7R[2S,3S,4R,5R(1E,3E,5E)]]],- 4S,6S(1E,3E)]-[partial]-
4-Pyrimidineaceticacid, a,2-diamino-1,4,5,6-tetrahydro-6-hydroxy-,(aS,4R,6S)-
(4R,6S)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide hydrochloride
5,12-Naphthacenedione,8-ethyl-7,8,9,10-tetrahydro-1,4,6,8,11-pentahydroxy-7-[[2,3,6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,6S)-tetrahydro-6-methyl-5-[[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]- (9CI)
5,12-Naphthacenedione,8-ethyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-7-[[2,3,6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,6S)-tetrahydro-6-methyl-5-[[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]-,(7R,8R)-
2-Heptanone, 6-methyl-7-[(tetrahydro-2H-pyran-2-yl)oxy]-, (6S)-